Cathy Eng

27.2k citations
347 papers · 20.4k · 15 hit papers · h-index 69

Impact in

  • Oncology top 0.05%
    • Colorectal Cancer Treatments and Studies
    • Colorectal Cancer Surgical Treatments
    • Cancer Immunotherapy and Biomarkers
  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 118
    • Colorectal Cancer Surgical Treatments 62
    • Cancer Immunotherapy and Biomarkers 12
    • Colorectal Cancer Screening and Detection 11
    • Colorectal and Anal Carcinomas 67
    • Intraperitoneal and Appendiceal Malignancies 26

Cathy Eng

329 papers receiving 19.9k citations

Cathy Eng's Hit Papers

Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal Cancer 2025 · 55 citations
550+7+14Years since publication2505007501k

Peers

Cathy Eng
Comparison fields: 5 of 141
  • Oncology 11.7k
  • Hepatology 1.3k
  • Cancer Research 1.3k
  • Surgery 3.3k
  • Pathology and Forensic Medicine 819
Replace Tanios Bekaii‐Saab with:
Tanios Bekaii‐Saab United States
Axel F. Grothey United States
Robert A. Wolff United States
Werner Scheithauer Austria
Dirk Arnold Germany
Olivier Bouché France
Per Pfeiffer Denmark
Joseph M. Herman United States
Michael James Overman United States
Pascal R. Hammel France
Cathy Eng relative to Tanios Bekaii‐Saab United States Tanios Bekaii‐Saab's profile →
Citations per field
00.5×1.7×
Tanios Bekaii‐Saab · 1×
Citations per year

Countries citing papers authored by Cathy Eng

Since Specialization
Citations

This map shows the geographic impact of Cathy Eng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Eng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Eng more than expected).

Fields of papers citing papers by Cathy Eng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Eng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Eng. The network helps show where Cathy Eng may publish in the future.

Co-authors

The 25 scholars most cited alongside Cathy Eng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cathy Eng Line = papers co-authored together Cathy Eng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 347 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Hit paper breakdown →
20091093
2
Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases
Hit paper breakdown →
20061031
3
Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases
Hit paper breakdown →
2005891
4
EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
Hit paper breakdown →
2008776
5
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group
Hit paper breakdown →
2020535
6 2008469
7
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Hit paper breakdown →
2017460
8
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
Hit paper breakdown →
2019460
9
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Hit paper breakdown →
2022433
10 2012418
11 2009412
12 2009353
13
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
Hit paper breakdown →
2017317
14 2011309
15
Antiemetics: ASCO Guideline Update
Hit paper breakdown →
2020297
16
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
Hit paper breakdown →
2020295
17 2007293
18 2007281
19
Colorectal cancer
Hit paper breakdown →
2024244
20 2017237

About Cathy Eng

Cathy Eng is a scholar working on Oncology, Surgery, Pathology and Forensic Medicine, Cancer Research and Hepatology, having authored 347 papers that have together received 20.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (118 papers), Colorectal and Anal Carcinomas (67 papers), Colorectal Cancer Surgical Treatments (62 papers), Intraperitoneal and Appendiceal Malignancies (26 papers), Genetic factors in colorectal cancer (22 papers), Cancer Genomics and Diagnostics (15 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Colorectal Cancer Screening and Detection (11 papers). The work is most often cited by research in Oncology (11.7k citations), Hepatology (1.3k citations), Cancer Research (1.3k citations), Surgery (3.3k citations) and Pathology and Forensic Medicine (819 citations). Cathy Eng has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Scott Kopetz, George J. Chang, Michael James Overman, Jean‐Nicolas Vauthey, Robert A. Wolff, Miguel A. Rodrı́guez-Bigas, John Michael Skibber, Prajnan Das, Eddie K. Abdalla and Steven A. Curley. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics and Clinical Colorectal Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact